• khi@asn-online.org
  • 202-640-4660
Kidney Health Initiative Kidney Health Initiative
  • Membership
    • Members
    • Join
  • Priority Areas
    • COVID-19
    • Collaboration & Partnership
    • Conducting Clinical Trials
    • Patient-Centered Tools for Regulators
    • Real World Evidence & Roadmapping
  • Collaborate
    • Submit a Project
    • Register for Events
    • Volunteer Opportunities
  • For Patients
  • About
    • Mission
    • Board of Directors
    • Patient & Family Partnership Council
    • FAQs
    • News
  • Membership
    • Members
    • Join
  • Priority Areas
    • COVID-19
    • Collaboration & Partnership
    • Conducting Clinical Trials
    • Patient-Centered Tools for Regulators
    • Real World Evidence & Roadmapping
  • Collaborate
    • Submit a Project
    • Register for Events
    • Volunteer Opportunities
  • For Patients
  • About
    • Mission
    • Board of Directors
    • Patient & Family Partnership Council
    • FAQs
    • News

Conduct of Clinical Trials

»

More Information

  • Membership
  • Priority Areas
  • Collaborate
  • For Patients
  • About

Search

Conduct of Clinical Trials

Current Projects

  • Drug Development in Children with Kidney Diseases
  • Endpoints for Enteric Hyperoxaluria Clinical Trials
  • Data Standards for Kidney Failure
  • Involving Kidney Patients in Cardiovascular Trials
  • Surrogate Endpoints in FSGS

Completed Projects

  • Clinical Trial Endpoints for Dialysis Vascular Access
  • Endpoints for Primary Hyperoxaluria Clinical Trials
  • Data Harmonization in Kidney Transplantation
  • Data Standards in Diabetic Kidney Disease
  • Outcome Measures in Lupus Nephritis Trials
  • Pragmatic Challenges in Dialysis: Challenges and Opportunities
  • Pharmacokinetics in Patients Receiving Continuous Renal Replacement Therapy
  • Regulatory Policies and Positions Affecting Device Approval in the US
  • Patient-Reported Outcome Measures for Novel Renal Devices
  • Surrogate Endpoints in IgA Nephropathy

Latest KHI News

Kidney Health Initiative Urges Investigators to Include People with Kidney Diseases in Clinical Trials for Coronavirus 2019 (COVID-19) Therapies

Clinical trials often exclude people with kidney diseases. This practice could have significant consequences, if continued, during the Coronavirus – 2019 (COVID-19) pandemic and for the 37 million Americans with kidney diseases who are at high risk of severe disease.

6/9/2020

Quick Links

  • Projects
  • Patient Info
  • Publications
  • Research Trials
  • KHI Members
  • Board of Directors
  • Events & Meetings
  • Latest News
  • Conflict of Interest
  • FAQ
  • Contact

KHI on Instagram

A Public-Private Partnership



KHI was founded in 2012 as a partnership between ASN and the FDA.

© American Society of Nephrology  •  Privacy Policy